[{"Assets_0_Q2_USD":264975000.0,"CommonStockSharesOutstanding_0_Q2_shares":36064517.0,"NetIncomeLoss_1_Q2_USD":-15593000.0,"NetIncomeLoss_2_Q2_USD":-28224000.0,"StockholdersEquity_0_Q2_USD":187585000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170801"}]